US 8987227
Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use
granted A61PA61P31/14
Quick answer
US patent 8987227 (Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use) held by Alnylam Pharmaceuticals, Inc. expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P31/14